Zuari Agro Chemicals Ltd

Zuari Agro Chemicals Ltd

₹ 209 1.96%
22 Jul 4:01 p.m.
About

Incorporated in 1967, Zuari Agro Chemicals Ltd manufactures, trades and marikets chemical fertilizers and fertilizer
products[1]

Key Points

Business Overview:[1][2]
ZACL is the flagship company of Adventz Group. It is also the holding company for the other agri-business operations of the Adventz Group. Company is a single-window agricultural solution provider and manufacturer of high-quality complex fertilizers of various grades along with micro nutrients and speciality fertilizers. Company manufactures and markets Single Super Phosphate (SSP) through its brand Jai Kisaan

  • Market Cap 874 Cr.
  • Current Price 209
  • High / Low 260 / 135
  • Stock P/E 40.8
  • Book Value 48.2
  • Dividend Yield 0.00 %
  • ROCE 14.8 %
  • ROE 11.5 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 4.33 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoters have pledged 46.8% of their holding.
  • Earnings include an other income of Rs.150 Cr.
  • Debtor days have increased from 85.1 to 113 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Fertilizers Industry: Fertilizers

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
-0 -0 32 25 26 52 28 46 39 41 15 10 17
10 2 34 27 27 54 44 50 43 42 28 16 21
Operating Profit -10 -2 -2 -2 -1 -1 -16 -4 -4 -2 -13 -6 -3
OPM % -7% -8% -4% -2% -59% -9% -10% -4% -91% -55% -18%
26 6 27 -11 23 1,134 3 3 -639 9 24 3 113
Interest 17 30 31 28 26 22 27 26 26 26 26 24 26
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -2 -28 -7 -42 -5 1,111 -42 -28 -670 -19 -17 -27 84
Tax % -0% -0% -0% -0% 23% 23% -12% -24% -26% -0% -0% -0% -0%
-2 -28 -7 -42 -6 850 -36 -21 -499 -19 -17 -27 84
EPS in Rs -0.54 -6.67 -1.67 -10.01 -1.49 202.12 -8.65 -5.06 -118.54 -4.44 -3.93 -6.45 19.90
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
5,233 5,173 5,504 5,264 4,077 4,648 4,731 50 0 83 165 83
5,025 4,996 5,281 5,071 3,780 4,303 4,639 634 165 91 189 107
Operating Profit 208 177 223 193 296 344 92 -584 -165 -8 -24 -24
OPM % 4% 3% 4% 4% 7% 7% 2% -1,162% -149,673% -9% -15% -28%
57 125 49 103 -7 53 -23 758 50 45 501 150
Interest 210 260 233 301 330 316 377 157 118 116 101 101
Depreciation 24 21 18 32 39 43 43 8 4 4 4 3
Profit before tax 30 21 21 -37 -80 39 -351 10 -237 -82 371 21
Tax % 20% -26% 40% -75% -24% 22% -6% 2,090% -0% 1% 21% -0%
24 26 12 -9 -60 30 -329 -189 -237 -83 294 21
EPS in Rs 5.81 6.22 2.94 -2.15 -14.35 7.21 -78.21 -45.00 -56.38 -19.84 69.87 5.09
Dividend Payout % 52% 48% 68% -93% -7% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: -34%
5 Years: -55%
3 Years: 810%
TTM: -50%
Compounded Profit Growth
10 Years: 9%
5 Years: 16%
3 Years: 28%
TTM: 117%
Stock Price CAGR
10 Years: 1%
5 Years: 12%
3 Years: 15%
1 Year: 31%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 42 42 42 42 42 42 42 42 42 42 42 42
Reserves 752 764 761 747 620 632 274 75 -151 -193 128 161
2,914 2,614 2,382 3,353 3,096 3,140 3,521 1,804 909 1,229 656 632
674 956 1,244 764 949 1,246 1,869 1,735 2,428 2,103 260 240
Total Liabilities 4,382 4,376 4,430 4,906 4,707 5,060 5,706 3,656 3,229 3,180 1,087 1,075
188 236 266 369 487 506 545 493 80 75 65 62
CWIP 81 78 98 89 129 114 119 121 -0 -0 1 2
Investments 198 329 329 371 911 886 751 1,175 1,184 1,549 867 872
3,916 3,733 3,737 4,078 3,180 3,554 4,291 1,868 1,965 1,557 154 137
Total Assets 4,382 4,376 4,430 4,906 4,707 5,060 5,706 3,656 3,229 3,180 1,087 1,075

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
103 357 639 -397 786 279 -76 2,065 525 539 9 3
-106 -32 -237 -374 -2 -17 -39 56 -83 95 683 129
-173 -481 -403 773 -785 -235 89 -2,076 -437 -685 -689 -116
Net Cash Flow -176 -155 -1 2 -1 27 -26 45 4 -51 4 16

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 207 202 176 188 198 173 186 5,964 33 47 95 113
Inventory Days 51 51 48 37 55 71 124 2,396 9,380 118 105 164
Days Payable 41 53 80 45 74 99 151 13,217 131,144 797 523 781
Cash Conversion Cycle 216 200 143 180 179 145 159 -4,857 -121,731 -631 -323 -504
Working Capital Days 211 195 147 190 165 148 147 -3,942 -2,449,581 -822 -346 -725
ROCE % 7% 6% 8% 8% 8% 10% 4% -19% -9% 4% -1% 15%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
65.04% 65.04% 65.04% 65.28% 65.28% 65.28% 65.28% 65.28% 65.28% 65.28% 65.28% 65.28%
0.95% 1.05% 1.01% 0.84% 1.43% 1.10% 1.13% 1.09% 1.02% 1.58% 1.27% 1.08%
2.11% 1.77% 1.42% 1.43% 1.08% 1.00% 1.00% 1.00% 1.00% 1.00% 1.00% 0.09%
0.23% 0.28% 0.28% 0.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
31.66% 31.86% 32.24% 32.17% 32.22% 32.62% 32.58% 32.62% 32.70% 32.13% 32.46% 33.55%
No. of Shareholders 29,59628,69828,10230,01732,22530,90830,99631,69732,12733,84537,65539,757

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents